Mining the Gastric Cancer Secretome: Identification of GRN as a Potential Diagnostic Marker for Early Gastric Cancer
- 2 February 2012
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Proteome Research
- Vol. 11 (3) , 1759-1772
Abstract
Gastric cancer is the second leading cause of cancer deaths worldwide, and currently, there are no clinically relevant biomarkers for gastric cancer diagnosis or prognosis. In this study, we applied a 2D-LC-MS/MS based approach, in combination with iTRAQ labeling, to study the secretomes of the gastric cancer cell lines AGS and MKN7. By performing a comparative analysis between the conditioned media and the whole cell lysates, our workflow allowed us to differentiate the bona fide secreted proteins from the intracellular contaminants within the conditioned media. Ninety proteins were found to have higher abundance in the conditioned media as compared to the whole cell lysates of AGS and MKN7 cells. Using a signal peptide and nonclassical secretion prediction tool and an online exosome database, we demonstrated that up to 92.2% of these 90 proteins can be exported out of the cells by classical or nonclassical secretory pathways. We then performed quantitative comparisons of the secretomes between AGS and MKN7, identifying 43 differentially expressed secreted proteins. Among them, GRN was found to be frequently expressed in gastric tumor tissues, but not in normal gastric epithelia by immunohistochemistry. Sandwich ELISA assay also showed elevation of serum GRN levels in gastric cancer patients, particularly those with early gastric cancer. Receiver operating characteristic (ROC) curves analysis confirmed that serum GRN can provide diagnostic discriminations for gastric cancer patientsKeywords
This publication has 33 references indexed in Scilit:
- Identification of Five Candidate Lung Cancer Biomarkers by Proteomics Analysis of Conditioned Media of Four Lung Cancer Cell LinesMolecular & Cellular Proteomics, 2009
- Discovery of Retinoblastoma-Associated Binding Protein 46 as a Novel Prognostic Marker for Distant Metastasis in Nonsmall Cell Lung Cancer by Combined Analysis of Cancer Cell Secretome and Pleural Effusion ProteomeJournal of Proteome Research, 2009
- Identification of potential lung cancer biomarkers using an in vitro carcinogenesis modelExperimental & Molecular Medicine, 2008
- Cathepsin D Is Secreted from M-BE Cells: Its Potential Role as a Biomarker of Lung CancerJournal of Proteome Research, 2007
- Elevation of serum l-lactate dehydrogenase B correlated with the clinical stage of lung cancerLung Cancer, 2006
- Biomarker Discovery from Pancreatic Cancer Secretome Using a Differential Proteomic ApproachMolecular & Cellular Proteomics, 2006
- Prospective study of peritoneal recurrence after curative surgery for gastric cancerBritish Journal of Surgery, 2003
- The microenvironment of the tumour–host interfaceNature, 2001
- Signal Peptide-Dependent Protein Transport in Bacillus subtilis : a Genome-Based Survey of the SecretomeMicrobiology and Molecular Biology Reviews, 2000
- Risk factors which predict pattern of recurrence after curative surgery for patients with advanced gastric cancerSurgical Oncology, 1992